DK1200437T3 - Fremgangsmåde til fremstilling af optisk rene tetrahydropteriner og derivater deraf, især optisk rene tetrahydrofolsyre og optisk rene derivater deraf ved stereospecifik hydrogenering - Google Patents

Fremgangsmåde til fremstilling af optisk rene tetrahydropteriner og derivater deraf, især optisk rene tetrahydrofolsyre og optisk rene derivater deraf ved stereospecifik hydrogenering

Info

Publication number
DK1200437T3
DK1200437T3 DK00956176T DK00956176T DK1200437T3 DK 1200437 T3 DK1200437 T3 DK 1200437T3 DK 00956176 T DK00956176 T DK 00956176T DK 00956176 T DK00956176 T DK 00956176T DK 1200437 T3 DK1200437 T3 DK 1200437T3
Authority
DK
Denmark
Prior art keywords
optically pure
derivatives
folic acid
hydrogenation
reaction medium
Prior art date
Application number
DK00956176T
Other languages
English (en)
Inventor
Hans Rudolf Mueller
Rudolf Moser
Viola Groehn
Benoit Pugin
Original Assignee
Eprova Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eprova Ag filed Critical Eprova Ag
Application granted granted Critical
Publication of DK1200437T3 publication Critical patent/DK1200437T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
DK00956176T 1999-07-14 2000-07-12 Fremgangsmåde til fremstilling af optisk rene tetrahydropteriner og derivater deraf, især optisk rene tetrahydrofolsyre og optisk rene derivater deraf ved stereospecifik hydrogenering DK1200437T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH01301/99A CH694251A5 (de) 1999-07-14 1999-07-14 Herstellung von Tetrahydropterin und Derivaten.
PCT/EP2000/006646 WO2001004120A1 (de) 1999-07-14 2000-07-12 Verfahren zur herstellung von optisch reinen tetrahydropterinen und derivaten, im speziellen optisch reiner tetrahydrofolsäure und ihren derivaten, durch stereospezifische hydrierung

Publications (1)

Publication Number Publication Date
DK1200437T3 true DK1200437T3 (da) 2004-07-12

Family

ID=4207242

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00956176T DK1200437T3 (da) 1999-07-14 2000-07-12 Fremgangsmåde til fremstilling af optisk rene tetrahydropteriner og derivater deraf, især optisk rene tetrahydrofolsyre og optisk rene derivater deraf ved stereospecifik hydrogenering

Country Status (13)

Country Link
US (2) US7816525B1 (da)
EP (1) EP1200437B1 (da)
JP (1) JP5121105B2 (da)
CN (2) CN100381442C (da)
AT (1) ATE261446T1 (da)
AU (1) AU6822900A (da)
CA (1) CA2378852C (da)
CH (1) CH694251A5 (da)
DE (1) DE50005609D1 (da)
DK (1) DK1200437T3 (da)
ES (1) ES2218203T3 (da)
PT (1) PT1200437E (da)
WO (1) WO2001004120A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH694251A5 (de) * 1999-07-14 2004-10-15 Eprova Ag Herstellung von Tetrahydropterin und Derivaten.
JP4562736B2 (ja) * 2004-11-17 2010-10-13 日本曹達株式会社 光学活性アルコールの製造方法
CN1962658B (zh) * 2005-11-10 2010-05-12 北京大学 一种四氢吡啶并[3,2-d]嘧啶类化合物及制备抗肿瘤药物的用途
KR101057576B1 (ko) * 2007-08-16 2011-08-17 에스케이종합화학 주식회사 선택적 에틸렌 올리머고화 촉매계
US20100047314A1 (en) * 2008-08-22 2010-02-25 Osteogenex Inc. Folinic acid derivatives for promoting bone growth
JOP20180009A1 (ar) 2017-02-06 2019-01-30 Gilead Sciences Inc مركبات مثبط فيروس hiv
AU2019297309B2 (en) * 2018-07-06 2024-08-29 Merck Patent Gmbh Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl ester
TWI829205B (zh) 2018-07-30 2024-01-11 美商基利科學股份有限公司 抗hiv化合物
CN113603691B (zh) * 2021-08-12 2022-08-26 连云港冠昕医药科技有限公司 L-5-甲基四氢叶酸钙的制备工艺
CN115656372B (zh) * 2022-10-27 2024-10-11 北京斯利安药业有限公司 一种s-四氢叶酸异构体手性分析方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53131298A (en) * 1977-03-18 1978-11-15 Ube Ind Ltd Production of phosgene
JPS5959697A (ja) * 1982-08-27 1984-04-05 エフ・ホフマン―ラ　ロシユ　アーゲー リン化合物
JPS60178887A (ja) * 1984-02-23 1985-09-12 Kanegafuchi Chem Ind Co Ltd ５，６，７，８−テトラヒドロ−ｌ−ビオプテリンの製造法
JPS61100583A (ja) * 1984-10-23 1986-05-19 Mitsui Toatsu Chem Inc ５，６，７，８−テトラヒドロ葉酸の製造方法
GB8501919D0 (en) * 1985-01-25 1985-02-27 Shell Int Research Carbonylation of allenically unsaturated compounds
EP0256982B1 (de) * 1986-08-04 1991-08-28 Ciba-Geigy Ag Verfahren zur Herstellung von optisch aktiven sekundären Arylaminen
KR880007418A (ko) * 1986-12-10 1988-08-27 오노 알버어스 공역 디엔의 선택적 카르보닐화 방법 및 이를 위한 유기 질소-함유 열기를 갖지 않는 촉매 시스템
DK0432441T3 (da) * 1989-12-11 1996-07-29 American Cyanamid Co Fremgangsmåde til fremstilling af optisk rene diastereoisomere af tetrahydrofolatforbindelser
CH681303A5 (da) * 1991-01-16 1993-02-26 Eprova Ag
CH683261A5 (it) 1991-10-10 1994-02-15 Applied Pharma Res Procedimento per la preparazione dell'acido metiltetraidrofolico nella forma (6(R,S)(-))N-5 e separazione del diastereoisomero attivo (6(S)(-))N-5) sotto forma di sali.
CH683690A5 (de) 1991-12-21 1994-04-29 Sapec Fine Chemicals Verfahren zur Herstellung von diastereoisomerenreinen Tetrahydrofolaten.
DE4200933A1 (de) 1992-01-16 1993-07-22 Basf Ag Verfahren zur diastereoselektiven hydrierung von folsaeure zu tetrahydrosolsaeure
CH686672A5 (de) 1992-12-01 1996-05-31 Cerbios Pharma Sa Verfahren zur Herstellung von (6S)-5,6,7,8-Tetrahydrofolsaeure.
CH686369A5 (de) 1994-05-09 1996-03-15 Eprova Ag Stabile kristalline (6S)- und (6R)-Tetrahydrofolseure.
TW272949B (da) * 1994-07-22 1996-03-21 Taishal Kagaku Kogyo Kk
CH689831A5 (de) * 1995-11-07 1999-12-15 Eprova Ag Stabile kristalline Tetrahydrofolsaeure-Salze.
US6169192B1 (en) * 1996-07-10 2001-01-02 Novartis Ag Functionalized ferrocenyldiphosphines, a process for their preparation and their use
US6162914A (en) * 1998-04-24 2000-12-19 Cerbios-Pharma S.A. Process for the reduction of pterins
CH695217A5 (de) * 1999-07-14 2006-01-31 Merck Eprova Ag Verfahren zur Trennung optischer Isomeren von Tetrahydrofolsäureestersalzen und Tetrahydrofolsäure.
CH694251A5 (de) * 1999-07-14 2004-10-15 Eprova Ag Herstellung von Tetrahydropterin und Derivaten.
WO2002002500A1 (en) * 2000-07-03 2002-01-10 Speedel Pharma Ag Preparation of (r)-2-alkyl-3-phenylpropionic acids
US20020197589A1 (en) * 2001-06-26 2002-12-26 Leapfrog Enterprises, Inc. Interactive educational apparatus with number array
GB0308801D0 (en) * 2003-04-16 2003-05-21 Celltech R&D Ltd Chemical compounds
US20070213540A1 (en) * 2006-03-09 2007-09-13 Degussa Ag Process for the hydrogenation of imines

Also Published As

Publication number Publication date
PT1200437E (pt) 2004-08-31
JP2003504370A (ja) 2003-02-04
CN100381442C (zh) 2008-04-16
CA2378852C (en) 2007-05-22
ATE261446T1 (de) 2004-03-15
US7816525B1 (en) 2010-10-19
CN1781919A (zh) 2006-06-07
EP1200437A1 (de) 2002-05-02
CN1360587A (zh) 2002-07-24
AU6822900A (en) 2001-01-30
CH694251A5 (de) 2004-10-15
WO2001004120A1 (de) 2001-01-18
CA2378852A1 (en) 2001-01-18
JP5121105B2 (ja) 2013-01-16
EP1200437B1 (de) 2004-03-10
CN1264842C (zh) 2006-07-19
DE50005609D1 (de) 2004-04-15
US20080306263A1 (en) 2008-12-11
ES2218203T3 (es) 2004-11-16

Similar Documents

Publication Publication Date Title
DK1200437T3 (da) Fremgangsmåde til fremstilling af optisk rene tetrahydropteriner og derivater deraf, især optisk rene tetrahydrofolsyre og optisk rene derivater deraf ved stereospecifik hydrogenering
CO5640116A2 (es) Produccion mejorada de sal de calcio de rosuvastatina
RS50257B (sr) Asimetrična sinteza pregabalina
Tronche et al. Polar substituent and solvent effects on the kinetics of radical reactions with thiols
ATE223274T1 (de) Entfernung von bindemittel
AU2003301508A1 (en) Processes for producing glutamic acid derivative and pyroglutamic acid derivative and novel intermediate for production
EP2278014A3 (en) Method for producing alcohol and carboxylic acid having optical activity
DE502005000613D1 (de) Verfahren zur enantioselektiven Reduktion von Ketoverbindungen durch Enzyme
ES2146988T3 (es) Poli(vinil-acetales) modificados con baja viscosidad en solucion.
DE50306111D1 (de) Hydroxydiphosphine und deren verwendung in der katalyse
RS51920B (en) PROCEDURE FOR THE SYNTHESIS OF IVABRADINE AND ITS ADDITIONAL SALTS WITH PHARMACEUTICALLY ACCEPTABLE ACID
Mohamadpour Four-component synthesis of Dihydropyrano [2, 3-c] pyrazole scaffolds using glycerol as green reaction media under catalyst-free conditions
DE50005271D1 (de) Kontinuierliches verfahren zur herstellung von zimtaldehyd- und dihydrozimtaldehydderivaten
ATE411257T1 (de) Verfahren zur herstellung von wasserstoffperoxid
Wolfson et al. Glycerol as an alternative green medium for carbonyl compound reductions
CN101456897B (zh) 3-羰基-4-氮杂-5α-雄甾化合物的制备方法
EP0955375A3 (en) Method for producing optically active 4-Halo-3-Hydroxybutyric acid ester
DE502008001265D1 (de) Verwendung des pigd-proteins zur katalyse von 1,4-additionen von 2-oxoalkanoaten an alpha, beta-ungesättigte ketone
Yanagisawa et al. Enantioselective protonation of alkenyl trifluoroacetates catalyzed by chiral tin methoxide.
AR045964A1 (es) Procedimiento para producir 1,3-propanodiol mediante hidrogenacion catalitica de 3-hidroxipropanal en presencia de un co-catalizador de hidratacion
TW200740767A (en) Process for the preparation of organic compounds
DK1498488T3 (da) Fremgangsmåde til fremstilling af lipid, der indeholder stærkt umættet fedtsyre
Jones et al. Use of pyridinium and flavin derivatives for recycling of catalystic amounts of NAD+ during preparative-scale horse liver alchohol dehydrogenase-catalysed oxidations of alcohols
DE69701840D1 (de) Verfahren zur asymmetrischen synthese von s-acylierten derivaten von 2-mercaptomethyl-3-phenylpropionsäure und deren verwendung zur synthese von n-mercaptoacyl aminosäure-derivaten
JP2016208863A (ja) 線維芽細胞の伸長促進方法